This longitudinal study aimed to determine the incidence and pathogenic implications of dual human immunodeficiency virus type 1 (HIV-1) infection in a cohort of female sex workers. Blood samples from 31 recently infected women were screened by use of a heteroduplex mobility assay and sequencing. The median viral load set point was 5404 copies/ mL ( ), which was measured by use of the bDNA assay. n p 22 Within 3 months of infection, 19% (6/31) of the women were dually infected with 2 distinct HIV-1 subtype C viruses. No evidence of superinfection was detected over the course of 24 months of follow-up, indicating that the risk of dual infection is highest around the time of the initial infection. There was a significant association between dual infection and elevated viral load set point.
Understanding HIV diversity and its relationship with the natural history of disease provides valuable insights into ascertaining the role diversity plays in disease progression, as well as understanding correlates of immunity from infection and superinfection. Shortly after infection, intraperson diversity is usually low, although 1 study of women has shown that there may be sex differences, with recently infected women harboring highly heterogeneous viral populations [1] . The virus evolves over time in response to selective pressure; some studies have shown a direct relationship between diversity and disease progression, and others have not [2, 3] . Recent studies have shown that dual infection with 2 HIV strains [4] or infection with multiple diverse variants [5] may be associated with faster disease progression. Dual infection can be a consequence of either cotransmission (infection with 2 strains at or close to the time of seroconversion) or superinfection (subsequent HIV-1 infection of an already-infected individual). Superinfection has been reported in only a few cases and is of interest since it provides information on protective immune responses [6] .
Viral load and CD4 + T cell counts are prognostic markers that are pivotal in predicting disease outcome [7] . There are limited data from African non-subtype-B-infected cohorts on viral loads after seroconversion, as well as on virological factors affecting the natural history of disease. The HIV epidemic in southern Africa is predominantly associated with heterosexually transmitted subtype C infection [8] . A recent study in India showed that HIV-1 subtype C viral load set point was not significantly different from that of subtype B; however, differences in viral load trajectory suggested a faster disease progression in subtype C infections [9] . To assess the effect of virological factors, such as dual infection, on clinical outcome, it is essential to understand the natural history of disease. Natural-history studies are relevant for future intervention, such as vaccine trials, in which viral load may be used as a secondary end point. Many vaccine trials are likely to take place in less-developed regions, where non-subtype B viruses dominate. The aim of the present study was to determine the incidence of dual infection at different time points after infection and to investigate the pathogenic implications of dual infection.
Subjects, materials, and methods. Blood samples were obtained from 31 HIV-1-seropositive female sex workers (FSWs) who were followed monthly as part of a microbicide phase 3 trial [10] . Informed consent was obtained from all participants, and human-experimentation guidelines of the institutional review board of the Nelson R. Mandela School of Medicine of Natal University and University of Cape Town were followed. Antibodies to HIV were detected by use of recombinant HIV- 1/HIV-2 ELIZAQ (Abbott) and confirmed by use of the Vironostika HIV Uniform II micro-ELISA 4 system (Omnimed). Viral loads were measured by use of bDNA (version 3.0; Bayer), and lymphocyte subsets were measured on fresh samples by use of FACscount (Becton Dickinson). HIV-1 env C2-C3 was amplified from viral RNA extracted from plasma. Primers for nested polymerase chain reaction (PCR) were envAR (5 -TGCTGCTCCCAAGAACCCAA-3 , at position 7783-7802 of the HIV HXB2 genome), envAF (5 -GAAAGAGCAGAAGACAGTGGC-3 , at position 6203-6223), BR (5 -AATTCTAGGTCCCCTCCTGA-3 , at position 7317-7337), and BF (5 -TAACACAAGCCTGTCCAAAGG-3 , at position 6826-6847). RNA was reverse transcribed to cDNA by use of ThermoScript reverse-transcriptase PCR (Invitrogen). To circumvent resampling and to ensure that the amplified variants reflected the viral populations in the blood, limiting dilution assays were performed, and amplifiable copies were determined by use of QUALITY (available at: http://ubik.microbiol.washington .edu/computing/quality) (table 1) .
Intraperson viral diversity was assessed by use of heteroduplex mobility assays (HMAs) [11] . Samples containing diverse populations or low amplifiable copy numbers were cloned. A total of 20-134 clones were screened, depending on the amplifiable copy number (у8-1000 copies). Total populations or cloned PCR products were sequenced (ABI PRISM dye terminator cycle-sequencing kit; Applied Biosysytems) (GenBank accession numbers AY585270-AY585306). Sequences were aligned by use of CLUSTALX (available at: ftp://ftp-igbmc.u-strasbg. fr/pub/ClustalX/) Maximum-likelihood trees were constructed with PAUP* 4.0b10 (Sinauer Associates) by use of tree bisection/reconnection branch swapping and substitution ratematrix parameters estimated via maximum likelihood (parameters used are available on request). Sequence gaps were ignored. DNA distance was determined under the Kimura Two Parameter model by use of MEGA (version 2.1; Molecular Evolution Genetic Analysis).
Results. Blood samples were obtained from 31 HIV-1-seropositive FSWs, of whom 25 were monitored for dual infection over the course of 25 months. Only 22 women had viral load and CD4 + T cell counts determined. Thirty-one women were enrolled within 6 months of HIV-1 infection. The median time from infection to enrollment was 36.5 days; time of infection was taken as the midpoint between the last HIV-seronegative and the first HIV-seropositive test result.
Intraperson diversity was assessed by use of an HMA with the 510-bp C2-C3 fragment. The resolution of HMA was determined by comparing the HMA banding patterns of total viral populations with the DNA distance between clones. In 8 samples in which the total-population PCR products showed a single band on HMA gels, the mean DNA distance between clones was !1%, with a range of 0.04%-0.86%. HMA of individual clones hybridized to an intraperson probe showed that PCR products could be resolved into 2 bands if the genetic difference was 11%.
In cases in which a smear or a distinct slow-migrating band of total-population PCR products was visualized on gels, the DNA distance had a range of 2.0%-12.5% ( ). It was therefore n p 10 assumed that a single heteroduplex band reflected diversity !2%. All 31 FSWs were infected with HIV-1 subtype C (figure 1). A total of 81% (25/31) of the women enrolled within 6 months of infection harbored highly homogenous viral populations (!2% in C2-C3); 19% (6/31) harbored diverse viral populations, including Du36, Du467, Du95, Du151, Du179, and Du62, with C2-C3 diversity of 9.21%, 7.0%, 8.83%, 11.21%, 11.0%, and 15.72%, respectively.
Dual infection with the same subtype can be defined as an infection with 2 phylogenetically distinct viruses that are no more closely related to each other than are another pair of epidemiologically unlinked viruses, with a mean pairwise DNA distance at least as distant as that to a group of unlinked sequences [4] . Viruses from 5 of these 6 women (Du36, Du95, Du151, Du179, and Du62) were grouped separately on a phylogenetic tree, demonstrating that these women were dually infected (figure 1). The sixth woman (Du467) harbored divergent strains that did not separate phylogenetically; how- ever, this woman was classified as dually infected, since the mean pairwise DNA distance of 7.0% between the 2 viral populations was more than the pairwise distances of various epidemiologically unlinked sequences within this cohort (pairwise distances of !6%). All dual infections were detected within 3 months of infection, suggesting either cotransmission or separate infections close to or at the time of seroconversion. All dual infections were confirmed on a second independent sample processed on separate occasions. The ratio of the 2 infecting viruses at the first time point varied, with a very low frequency (∼1 in 100) for Du36 and a higher frequency (12 in 20) for Du62. Dual infection of Du151 has been reported elsewhere [4] .
To investigate the incidence of superinfection, 25 women were screened at least twice during an 18-24-month period after infection, with a median interval from follow-up of 7 months. Despite risk-reduction counseling and provision of condoms, these women continued high-risk behavior, with estimated condom use of !25%, an average of 15 sex partners/ week, and HIV prevalence of 56% [12, 13] . From these figures, it is estimated that each individual had 327-437 HIV exposures/ year. Of these 25 women, 6 were dually infected at the first time point. Among the women with single infections, there was no evidence of superinfection, and sequences from women followed over time were grouped together on the phylogenetic tree (data not shown).
Twenty-two women were monitored over the course of 25 months for viral load and CD4 + T cell counts. One hundred thirty viral load measurements were available, with an average of 4 viral load measurements/woman. Consistent with acute infection, the viral loads within the first 3 months of infection were highly variable, ranging from 161 to 579,480 copies/mL ( ). To determine the time point at which individuals n p 10 reach a viral load set point, we compared median viral loads between time points. Viral loads were categorized into 2 groups, months and months, with women included only 6 ‫ע‬ 2 1 2 ‫ע‬ 3 if they had viral loads measured during both these periods ( ). Although there was an overall decrease, from 8652 n p 11 copies/mL (log 10 3.9; range, 50-751,260 copies/mL) to 5443 copies/mL (log 10 3.7; range, 50-756,660 copies/mL), this decrease was not significant. Therefore, for the present study, the single viral load measurement closest to 12 months (9-25 months) after infection was taken as a surrogate for viral load set point. Use of these time points was guided by studies with subtype B infections, in which the most prognostic time point was 12-18 months after infection [7] . The median viral load set point was 5404 copies/mL (log 10 3.7;
). n p 22 Women were classified into three categories on the basis of their viral load set points: low (undetectable to р1000 copies/ mL), medium (11000-40,000 copies/mL), and high (140,000 copies/mL). Three women had high viral loads, 1 of whom experienced rapid disease progression (Du151) and died within 2 years of infection [10] . Four women had low viral loads, 1 of whom had undetectable viral loads for 19 months. The majority of the women (15/22) had medium viral loads (1042-15,854 copies/mL). Seventy-one CD4 + T cell counts were available from 22 women 0-25 months after infection. The median CD4 + T cell counts for the low, medium, and high viral load categories were 523 ( ), 512 ( ), and 252 ( ) n p 4 n p 13 n p 2 cells/mL. The differences in CD4 + T cell counts between viral load categories were not significant.
Viral load, CD4 + T cell counts, and diversity data were available for 19 of the 31 women enrolled within 6 months of infection, of whom 4 were dually infected and 15 were singly infected (table 1) . There were no clinical data available for 2 of the dually infected women (Du36 and Du95). Viral diversity after transmission (!6 months) was compared with viral load set point at 12 months (table 1) . There was a significant association between dual infection and viral load (table 1) (P p .004, 2-tailed Fisher's exact test). Three women with dual infections (Du62, Du151, and Du467) had high viral load set points, and 1 (Du179) had a medium viral load set point (1359 copies/mL). None of the 15 women with single infections had high viral load set points. Although Du179 was dually infected and had a low viral load, at 22 months, she also had a low CD4 + T cell count (279 cells/mL) and was infected with an R5X4 virus at 19 months after infection [14] .
Discussion. The present study is the first natural-history study to follow highly exposed HIV-1 subtype C-infected African women from the time of seroconversion and to show the incidence of dual infection and its effect on viral load set point. The data in the present study support those of a previous study that predominantly focused on subtype B ( ) but included n p 4 the individual in the present cohort who experienced rapid progression (Du151). This previous study reported on 5 dually infected individuals who progressed to AIDS or died within 2 years of infection. The incidence of dual infection in the present study's subtype C-infected cohort of high-risk women (19%) was higher than the incidence found in a subtype B-infected cohort of men (12%) [4] . The risk of dual infection was highest close to the time of infection. However, intraperson viral diversity may be underestimated in individuals with low amplifiable copy numbers, and HMA may not detect dual infections if the second virus is present at a low frequency.
The viral load set point in the cohort in the present study was log 10 3.7, which is lower than the viral load set point in a number of other seroconversion cohort studies (approximately log 10 4.5), including studies in India, Kenya, and the United States. The method for estimating viral loads and the definition of "viral load set point" differed between cohorts: the Kenyan and US studies used a similar definition of "viral load set point" as that used in the present study; the Indian study used an average of measurements collected from infection over the course of 2 years.
In addition, the present study used bDNA to determine viral loads, whereas the other studies used the Gen-Probe Quantitative HIV-1 assay or Amplicor (Roche Diagnostics). However, the low viral load set point found in the present study could also reflect sex differences, as has been seen in early infections in other cohorts of women [1] . Alternatively, highly exposed women may have mucosal responses that enable them to better control viral replication once they become infected.
The present study has provided some insight into natural control of virus in a highly exposed cohort, and larger studies will be needed to determine whether multiple exposures at the mucosal interface leads to development of protective immunity and consequently lower viral loads. In addition, it is not known whether dual infection or transmission of multiple divergent variants [4, 5] enables rapid adaptation and immune escape, resulting in faster disease progression, or whether people who are genetically predisposed to experience rapid disease progression are unable to control viral diversity, enabling establishment of dual infections. The possible pathogenic implications of dual infection suggest that HIV-concordant sex partners should continue to protect themselves from dual infection. Understanding the protective mechanisms associated with dual infection would provide vital information useful to our understanding of correlates of protection and contribute to vaccine design.
